for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shanghai RAAS Blood Products Co., Ltd.

002252.SZ

Latest Trade

8.27CNY

Change

-0.16(-1.90%)

Volume

37,676,082

Today's Range

8.26

 - 

8.52

52 Week Range

5.75

 - 

17.57

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
8.43
Open
8.44
Volume
37,676,082
3M AVG Volume
1,166.04
Today's High
8.52
Today's Low
8.26
52 Week High
17.57
52 Week Low
5.75
Shares Out (MIL)
4,974.62
Market Cap (MIL)
41,140.13
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Shanghai RAAS Blood Products Returns To Net Profit In H1

Holdings In Shanghai RAAS' Controlling Shareholder Could Be Reduced Due To Margin Call Defaults

Shanghai Raas Blood Products Expects To Return To Net Profit In H1

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shanghai RAAS Blood Products Co., Ltd.

Shanghai RAAS Blood Products Co., Ltd. is a China-based company principally engaged in the research and development, manufacture and distribution of blood products. The Company's main products include human albumin and human immunoglobulin for intravenous injection, human coagulation factors and others. The Company is also engaged in the distribution of Chinese medicine products and foods. The Company distributes its products within domestic market and to overseas markets.

Industry

Biotechnology & Drugs

Contact Info

2009, Wangyuan Road, Fengxian District

+86.21.22130888

http://www.raas-corp.com

Executive Leadership

Jie Chen

Chairman of the Board, General Manager

Kai Huang

Vice Chairman of the Board

Zheng Liu

Chief Financial Officer, Secretary of the Board, Deputy General Manager

Jun Xu

Deputy General Manager, Director

Jun Yin

Executive Deputy General Manager, Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
19.22
Price To Book (MRQ)
3.65
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-2.17
Return on Equity (TTM)
-2.08

Latest News

Shanghai RAAS in tie-up talks with U.S. blood products arm of Spain's Grifols

China's Shanghai RAAS Blood Products Co Ltd <002252.SZ> is in talks to combine with a U.S. subsidiary of Spanish blood products company Grifols <GRLS.MC>, the two companies said.

BRIEF-Shanghai RAAS Blood Products sees FY 2018 H1 net loss to be 437.4 mln yuan to 650 mln yuan

* Sees FY 2018 H1 net loss to be 437.4 million yuan to 650 million yuan

BRIEF-Shanghai RAAS Blood Products Says 2017 Net Profit Down 48.19 Percent Y/Y

* SAYS 2017 NET PROFIT DOWN 48.19 PERCENT Y/Y Source text in Chinese: https://bit.ly/2HM7fcV Further company coverage: (Reporting by Hong Kong newsroom)

BRIEF-Shanghai RAAS Blood Products To Swing To Red In Q1

* SAYS IT SEES Q1 NET LOSS AT 653.35-719.66 MILLION YUAN FROM NET PROFIT OF 222.23 MILLION YUAN ($35.43 million) YEAR AGO Source text in Chinese: https://bit.ly/2J6ZWdt Further company coverage: ($1 = 6.2729 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Shanghai RAAS Blood Products Plans Asset Acquisition, Share Trade Remains Suspended

* SAYS IT PLANS TO BUY TIANCHENG INTERNATIONAL INVESTMENT OR ITS SUBSIDIARY VALUED AT 16 BILLION YUAN ($2.53 billion) VIA SHARE ISSUE

BRIEF-Shanghai RAAS Blood Products passes review of high-tech enterprise recognition

* To enjoy a tax preference of 15 percent for three years from 2017 to 2019

BRIEF-Shanghai Raas Blood Products Expects 2017 Net Profit To Fall 39-49 Percent Y/Y

* SAYS IT EXPECTS 2017 NET PROFIT TO FALL 39-49 PERCENT Y/Y FROM 1.6 BILLION YUAN ($252.50 million) YEAR AGO Source text in Chinese: http://bit.ly/2DOv5ze Further company coverage: ($1 = 6.3366 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Shenzhen Exchange Filing Shows Block Trade Of Shanghai RAAS Blood Products Involving 199.8 Million Yuan

* FILING SHOWS BLOCK TRADE OF SHANGHAI RAAS BLOOD PRODUCTS CO LTD'S 10.43 MILLION SHARES INVOLVING 199.8 MILLION YUAN ($30.35 million) ON DEC 21 Source text in Chinese: http://bit.ly/2grA0v1 Further company coverage: ($1 = 6.5832 Chinese yuan renminbi) (Reporting by Hong...

BRIEF-Shenzhen exchange filing shows block trade of Shanghai RAAS' shares involving 537.5 mln yuan

* Filing shows block trade of Shanghai RAAS Blood Products Co Ltd's 27.8 million shares involving 537.5 million yuan ($81.08 million) on Nov 6

BRIEF-Shanghai RAAS Blood Products sees FY 2017 net profit to down 15 pct to up 15 pct

* Sees FY 2017 net profit to decrease by 15 percent to increase by 15 percent, or to be 1.37 billion yuan to 1.86 billion yuan

BRIEF-Shanghai RAAS Blood Products' net profits down in Q3, Jan-Sept

* Says Q3 net profit down 60.5 percent y/y at 231.3 million yuan ($34.88 million)

BRIEF-Shenzhen exchange filing shows block trade of Shanghai RAAS shares involving 295.3 mln yuan

* Disclosure shows block trade Of Shanghai RAAS Blood Products Co Ltd's 15.3 million shares involving 295.3 million yuan ($44.80 million) on Sept 21

BRIEF-Shanghai RAAS Blood Products scraps asset acquisition, share trade to resume

* Says it scraps asset acquisition plan, share trade to resume on Sept 21

BRIEF-Plan scrapped for Tsinghua Tongfang to acquire stake in Shanghai RAAS Blood Products

* Says it scraps asset restructuring plan which Tsinghua Tongfang planned to acquire 29.9 percent stake in the company

BRIEF-Shanghai RAAS Blood Products' H1 net profit up 9.3 pct y/y

* Says H1 net profit up 9.3 percent y/y at 708.8 million yuan ($106.48 million)

BRIEF-Tsinghuatongfang to acquire 29.9 pct stake in Shanghai RAAS Blood Products

* Says Tsinghuatongfang Co Ltd will acquire 29.9 percent stake in the co via cash, share issue

BRIEF-Shanghai RAAS Blood Products' preliminary H1 net profit up 8.7 pct y/y

* Says prelim H1 net profit up 8.7 percent y/y at 705.1 million yuan ($104.59 million)

BRIEF-Tsinghua Tongfang to acquire stake in Shanghai RAAS Blood Products

* Says Tsinghua Tongfang plans to buy up to 29.9 percent stake in the company, share trade remains suspended

BRIEF-Shanghai RAAS Blood Products says dividend payment date on June 20

* Says it will pay a cash dividend of 0.3 yuan per 10 shares (before tax) for 2016 to shareholders of record on June 19

BRIEF-Shanghai RAAS Blood Products unit sells Hubei-based pharma firm for 238 mln yuan

* Says its Zhengzhou unit has transferred Hubei-based pharma company to a Shenzhen investment company, for 238 million yuan

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up